跳至主要内容
临床试验/JPRN-UMIN000018780
JPRN-UMIN000018780已完成未知

The multicenter study for purposes of detection of prognostic factor of advanced stage pediatric lymphoblastic lymphoma treated with standard chemotherapy - The multicenter to detect prognostic factor of advanced stage pediatric lymphoblastic lymphoma treated with standard chemotherapy (ALB-NHL-14)

Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)0 个研究点目标入组 92 人开始时间: 2015年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 20years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Down syndrome. (2) Other previous illness of malignant tumor or previous therapy of organ transplantation including hematopoietc stem cells. (3) history of congenital or acquired immunodeficiency. (4) uncontrolled infection, including active tuberculosis infection and positive of HIV antibody. (5) pregnancy or high possibility of pregnancy and giving suck woman. (6) QTfc, corrected by Friderics formula as QTfc = QT/RR*1/3, is more than 0.45 seconds. (7) CNS hemorrage more than grade 3 of CACAE v4.0 (8) MDS, Ph1 positive (9) any inappropriate status judged by physician.

研究者

发起方
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

相似试验